MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm15093444

Медицинская библиотека · Journal of clinical medicine · 2026

Melatonin Supplementation and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Trials.

Ang Song Peng, Chia Jia Ee, Thirupathy Umabalan, Laezzo Madison, Jaiswal Vikash, Varon Joseph, Halma Matthew, Lee Eunseuk, Davidson George, Iglesias Jose

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Background

Melatonin has antioxidant and anti-inflammatory properties that may attenuate ischemia-reperfusion injury, but randomized cardiovascular trial data remain inconsistent.

Objectives

This study sought to evaluate the association of melatonin supplementation with cardiovascular outcomes across randomized trials.

Methods

We performed a systematic review and meta-analysis of randomized trials comparing melatonin with placebo, usual care, or no melatonin in patients with cardiovascular disease. PubMed, Embase, and CENTRAL were searched from inception to 1 January 2026. Random-effects models with Hartung-Knapp-Sidik-Jonkman confidence intervals were used. Prespecified outcomes included left ventricular ejection fraction (LVEF), change in LVEF, troponin, infarct size by cardiac magnetic resonance, heart failure outcomes, inflammatory and oxidative stress biomarkers, and adverse events.

Results

A total of 14 randomized controlled trials involving 1027 participants were included. Melatonin significantly improved change in LVEF from baseline to follow-up (mean difference: 3.95 percentage points; 95% CI: 1.70-6.20; p < 0.001), with the most consistent signal in coronary artery bypass grafting studies (mean difference: 4.65 percentage points; 95% CI: 2.56-6.74). Final LVEF was numerically higher with melatonin but not statistically significant. Troponin reduction was not significant. Narrative synthesis suggested lower inflammatory and oxidative stress markers after coronary artery bypass grafting and improvement in heart failure symptoms and quality of life, whereas infarct size findings in ST-segment elevation myocardial infarction were mixed and timing-dependent.

Conclusions

Melatonin was associated with improved LVEF change, particularly in coronary artery bypass grafting settings, but benefit was not consistently demonstrated across final LVEF, troponin, or infarct size outcomes.

Для цитирования: Ang Song Peng, Chia Jia Ee, Thirupathy Umabalan, Laezzo Madison, Jaiswal Vikash, Varon Joseph, Halma Matthew, Lee Eunseuk, Davidson George, Iglesias Jose. Melatonin Supplementation and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Trials.. Journal of clinical medicine. 2026. DOI: 10.3390/jcm15093444.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.